Fc-REZEPTOR-BINDENDE PROTEINE

European patent · EP2714084 · In force

Register entry

Publication number
EP2714084
Application number
EP12793948
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 1, 2012
Published
Apr 9, 2014
Granted
May 22, 2019
Protection ends at the latest
May 31, 2032
Next annual fee due
Jun 30, 2027
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
Priority
US 201161492617 P 02.06.2011
US 201161498266 P 17.06.2011
PCT application
PCT/US2012/040409 01.06.2012
PCT publication
WO2012/167039 06.12.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. May 29, 2021

    Transferred

    Owner
    Dyax Corp., 300 Shire Way, Lexington, MA 02421, USA → Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 29.05.2021

  7. May 22, 2019

    Granted

    Published in Swissreg on 22.05.2019

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP

Inventor

TENHOOR, Christopher

Hopkinton, MA 01748, US

SEXTON, Daniel, J.

Melrose, MA 02176, US

VISWANATHAN, Malini

Acton, MA 01720, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.